- Home
- ARQT vs CRGY Comparison
ARQT vs CRGY Comparison
Compare ARQT & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- CRGY
- Stock Information
- Founded
- ARQT 2016
- CRGY 1986
- Country
- ARQT United States
- CRGY United States
- Employees
- ARQT N/A
- CRGY N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- CRGY Oil & Gas Production
- Sector
- ARQT Health Care
- CRGY Energy
- Exchange
- ARQT Nasdaq
- CRGY Nasdaq
- Market Cap
- ARQT 2.0B
- CRGY 1.6B
- IPO Year
- ARQT 2020
- CRGY N/A
- Fundamental
- Price
- ARQT $13.80
- CRGY $8.20
- Analyst Decision
- ARQT Strong Buy
- CRGY Buy
- Analyst Count
- ARQT 6
- CRGY 11
- Target Price
- ARQT $18.80
- CRGY $17.56
- AVG Volume (30 Days)
- ARQT 2.6M
- CRGY 4.9M
- Earning Date
- ARQT 05-13-2025
- CRGY 05-05-2025
- Dividend Yield
- ARQT N/A
- CRGY 6.19%
- EPS Growth
- ARQT N/A
- CRGY N/A
- EPS
- ARQT N/A
- CRGY N/A
- Revenue
- ARQT $196,542,000.00
- CRGY $2,930,919,000.00
- Revenue This Year
- ARQT $60.21
- CRGY $31.67
- Revenue Next Year
- ARQT $40.21
- CRGY $0.13
- P/E Ratio
- ARQT N/A
- CRGY N/A
- Revenue Growth
- ARQT 229.74
- CRGY 23.01
- 52 Week Low
- ARQT $6.99
- CRGY $6.83
- 52 Week High
- ARQT $17.75
- CRGY $16.94
- Technical
- Relative Strength Index (RSI)
- ARQT 46.44
- CRGY 38.23
- Support Level
- ARQT $12.51
- CRGY $6.83
- Resistance Level
- ARQT $13.67
- CRGY $8.09
- Average True Range (ATR)
- ARQT 1.43
- CRGY 0.76
- MACD
- ARQT -0.27
- CRGY -0.01
- Stochastic Oscillator
- ARQT 34.83
- CRGY 33.55
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.